Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Organovo Holdings, Inc.    ONVO

ORGANOVO HOLDINGS, INC.

(ONVO)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/12/2019 11/13/2019 11/14/2019 11/15/2019 11/18/2019 Date
0.3917(c) 0.37(c) 0.3839(c) 0.4367(c) 0.4566(c) Last
358 918 326 351 322 450 1 497 880 1 583 264 Volume
+2.94% -5.54% +3.76% +13.75% +4.56% Change
More quotes
Financials (USD)
Sales 2020 3,64 M
EBIT 2020 -28,7 M
Net income 2020 -28,3 M
Debt 2020 -
Yield 2020 -
Sales 2021 3,96 M
EBIT 2021 -32,5 M
Net income 2021 -32,5 M
Debt 2021 -
Yield 2021 -
P/E ratio 2020 -2,08x
P/E ratio 2021 -2,17x
Capi. / Sales2020 16,4x
Capi. / Sales2021 15,0x
Capitalization 59,6 M
More Financials
Company
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused... 
More about the company
Latest news on ORGANOVO HOLDINGS, INC.
11/07ORGANOVO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
10/11ORGANOVO HOLDINGS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fi..
AQ
10/03ORGANOVO HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
10/02Organovo Acknowledges Receipt of Proposal
GL
10/02ORGANOVO : Acknowledges Receipt of Proposal
AQ
09/05ORGANOVO HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (f..
AQ
08/08ORGANOVO : Fiscal 1Q Earnings Snapshot
AQ
08/08ORGANOVO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
08/07ORGANOVO HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
08/07ORGANOVO : to Explore Strategic Alternatives and Implement Restructuring Plan
AQ
07/18Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Resul..
GL
07/09ORGANOVO HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/08Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoid..
GL
06/28ORGANOVO HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued ..
AQ
06/14ORGANOVO : to Present at Raymond James Life Sciences and MedTech Conference
AQ
More news
News in other languages on ORGANOVO HOLDINGS, INC.
2017ORGANOVO HOLDINGS INC : Veröffentlichung des Jahresergebnisses
2017ORGANOVO HOLDINGS INC : publication des résultats annuels
More news
Analyst Recommendations on ORGANOVO HOLDINGS, INC.
More recommendations
Sector news : Biotechnology & Medical Research - NEC
10:18aA lot happening on the M&A side
07:00aQiagen shares surge as diagnostics group says open to takeover talks
RE
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
11/14Walt Disney soars while Cisco disappoints
11/14THERMO FISHER SCIENTIFIC : Qiagen Shares Surge on Report Thermo Fisher Mulling D..
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart ORGANOVO HOLDINGS, INC.
Duration : Period :
Organovo Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORGANOVO HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price
Last Close Price 0,46  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Taylor J. Crouch President, Chief Executive Officer & Director
Kirk D. Malloy Chairman
Craig S. Kussman CFO & Principal Accounting Officer
Steven G. Hughes Chief Medical Officer
Richard E. Maroun Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORGANOVO HOLDINGS, INC.-54.37%57
IQVIA HOLDINGS INC.22.34%28 427
LONZA GROUP33.77%25 529
CELLTRION, INC.--.--%20 414
SEATTLE GENETICS, INC.104.25%19 667
INCYTE CORPORATION36.34%18 675